Abnormal genes and myocardial fatty acid metabolism in animal with hart dysfunction.
心脏功能障碍动物基因异常与心肌脂肪酸代谢。
基本信息
- 批准号:15390364
- 负责人:
- 金额:$ 7.94万
- 依托单位:
- 依托单位国家:日本
- 项目类别:Grant-in-Aid for Scientific Research (B)
- 财政年份:2003
- 资助国家:日本
- 起止时间:2003 至 2005
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
Dilated cardiomyopathy is a set of heterogeneous diseases of left ventricular dysfunction of unknown etiology, which has a variety of clinical courses and pathological findings. Long-chain fatty acids are one of the major cardiac energy substrates, so understanding long-chain fatty acid metabolism may help in elucidating the mechanisms of various heart diseases. Myocardial long-chain fatty acids metabolism was decreased in rats with heart failure. Although low-dose candesartan can block increases in blood pressure with circulating angiotensin same to the extent as high-close quinapril, it does not confer sufficient protection against injury from the rennin-angiotensin system in heart failure. Carvedilol has beneficial effects and protects cardiac adrenergic neurons in dilated cardiomyopathy.Glycogen synthase kinase (GSK) 3β is a multifunctional protein that positively regulates myocardial apoptosis and negatively regulates hypertrophy. However, the role of GSK3β in the diabetic myocardium is largely unknown. We found that GSK3β became more active (less phosphorylated at serine 9) via decreased Akt phosphorylation, in parallel to JNK activation, which correlated with increased activated caspase 3 and myocardial apoptosis 3 days after streptozotocin (STZ) injection in mice. However, 28 days after STZ injection, GSK3β became inactive, which correlated with the enhanced protein kinase C β2 and p38 MAPK expression, nuclear translocation of nuclear factor of activated T cells c3, cardiac hypertrophy and fibrosis. All of the above parameters were exacerbated in dominant negative 14-3-3 transgenic mice. Our results suggest that GSK3β together with 14-3-3 protein plays essential roles in the signaling of diabetic cardiomyopathy, and treatment with either losartan or tempol prevents these changes.
扩张型心肌病是一组病因不明的异质性左室功能不全疾病,其临床病程和病理表现多种多样。长链脂肪酸是心脏的主要能量底物之一,因此了解长链脂肪酸代谢可能有助于阐明各种心脏疾病的机制。心力衰竭大鼠心肌长链脂肪酸代谢降低。尽管低剂量坎地沙坦可以阻断循环血管紧张素引起的血压升高,其程度与高剂量喹那普利相同,但它不能提供足够的保护,防止心力衰竭时肾素-血管紧张素系统的损伤。卡维地洛对扩张型心肌病的心脏肾上腺素能神经元具有保护作用,糖原合成酶激酶(Glycogen synthase kinase,GSK)3β是一种多功能蛋白,可正性调节心肌细胞凋亡,负性调节心肌肥厚。然而,GSK 3 β在糖尿病心肌中的作用在很大程度上是未知的。我们发现,GSK 3 β通过Akt磷酸化减少而变得更活跃(丝氨酸9处磷酸化减少),与JNK激活平行,这与小鼠链脲佐菌素(STZ)注射后3天激活的caspase 3和心肌细胞凋亡增加相关。而注射STZ后28 d,心肌细胞中GSK 3 β失活,与蛋白激酶C β2和p38 MAPK表达增强、活化T细胞核因子c3核转位、心肌肥厚和纤维化有关。所有上述参数在显性阴性14-3-3转基因小鼠中均加重。我们的研究结果表明,GSK 3 β和14-3-3蛋白在糖尿病心肌病的信号传导中起着重要作用,氯沙坦或tempol治疗可预防这些变化。
项目成果
期刊论文数量(11)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Comparative Effects of Pranidipine with Amlodipine in Rats with Heart Failure
普拉地平与氨氯地平对心力衰竭大鼠的作用比较
- DOI:10.1159/000091746
- 发表时间:2006
- 期刊:
- 影响因子:3.1
- 作者:P. Veeraveedu;Kenichi Watanabe;Meilei Ma;N. Gurusamy;S. Palaniyandi;J. Wen;Paras Prakash;M. I. I. Wahed;Fadia Kamal;Sayaka Mito;Megumi Kunisaki;M. Kodama;Y. Aizawa
- 通讯作者:Y. Aizawa
Watanabe K et al.: "Comparative effects of perindopril with enalapril in rats with dilated cardiomyopathy."J Cardiovascul Pharmacol.. 42. S105-D109 (2003)
Watanabe K 等人:“培哚普利与依那普利对扩张型心肌病大鼠的比较作用。”J Cardiovascul Pharmacol.. 42. S105-D109 (2003)
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Comparative effects of quinapril with enalapril in rats with heart failure.
喹那普利与依那普利对心力衰竭大鼠的影响比较。
- DOI:
- 发表时间:2004
- 期刊:
- 影响因子:0
- 作者:Kenichi Watanabe
- 通讯作者:Kenichi Watanabe
Watanabe K et al.: "Immune-mediated myocarditis and interleukin-10 Inflammation and Cardiac Diseases.(Edited by Ciora Z Feuerstein.)"Birkhauser Verlag Basel. Switzerland.. 189-202. (2003)
Watanabe K 等人:“免疫介导的心肌炎和白细胞介素 10 炎症和心脏病。(由 Ciora Z Feuerstein 编辑)”Birkhauser Verlag Basel。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Role of IFN-γ-inducible protein-10 (IP-10/CXCL10) in the progression of pancreatitis-like injury in mice after murine retroviral infection.
IFN-γ诱导蛋白10(IP-10/CXCL10)在小鼠逆转录病毒感染后胰腺炎样损伤进展中的作用。
- DOI:
- 发表时间:2006
- 期刊:
- 影响因子:0
- 作者:Kawauchi Y;Suzuki K;Watanabe S;Yamagiwa S;Yoneyama H;Han G;Suresh SP;Punniyakoti TV;Watanabe K;Kawachi H;Okada Y;Shimizu F;Asakura H;Aoyagi Y;Narumi S.
- 通讯作者:Narumi S.
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
WATANABE Kenichi其他文献
Surveillance of amyloidosis in stranded and bycaught cetaceans off Hokkaido, Japan
日本北海道附近搁浅和兼捕鲸类淀粉样变性的监测
- DOI:
10.1292/jvms.18-0706 - 发表时间:
2019 - 期刊:
- 影响因子:1.2
- 作者:
NAKAGUN Shotaro;WATANABE Kenichi;MATSUISHI Takashi;KOBAYASHI Mari;KOBAYASHI Yoshiyasu - 通讯作者:
KOBAYASHI Yoshiyasu
WATANABE Kenichi的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('WATANABE Kenichi', 18)}}的其他基金
Pathological and genetic study of inclusion body disease of Japanese brown cattle.
日本褐牛包涵体病的病理和遗传学研究。
- 批准号:
19K15994 - 财政年份:2019
- 资助金额:
$ 7.94万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Non-destructive inspection of large structures using backscatter X-ray tomography
使用反向散射 X 射线断层扫描对大型结构进行无损检查
- 批准号:
25630430 - 财政年份:2013
- 资助金额:
$ 7.94万 - 项目类别:
Grant-in-Aid for Challenging Exploratory Research
Fast electron density imaging with third generation Compton scattered X -ray CT
第三代康普顿散射 X 射线 CT 快速电子密度成像
- 批准号:
23760824 - 财政年份:2011
- 资助金额:
$ 7.94万 - 项目类别:
Grant-in-Aid for Young Scientists (B)
Fatty acid metabolism of diabetic cardiomyopathy and failing heart
糖尿病心肌病和心力衰竭的脂肪酸代谢
- 批准号:
20590161 - 财政年份:2008
- 资助金额:
$ 7.94万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Investigation of new protective therapy of inner ear using a super anti-apoptotic protein, PTD-FNK
使用超级抗凋亡蛋白 PTD-FNK 的新型内耳保护疗法的研究
- 批准号:
16591731 - 财政年份:2004
- 资助金额:
$ 7.94万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Structural Evolution of Enzymes from Antarctic Psychrotrophs and Molecular Mechanism for Their Higher Activities at Low Temperatures
南极耐冷生物酶的结构演化及其低温高活性的分子机制
- 批准号:
13660096 - 财政年份:2001
- 资助金额:
$ 7.94万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Myocardial fatty acid metabolism and drug therapy in rats with heart failure.
心力衰竭大鼠心肌脂肪酸代谢和药物治疗。
- 批准号:
13670750 - 财政年份:2001
- 资助金额:
$ 7.94万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
相似海外基金
Small molecule modulation of 14-3-3 protein-protein interactions
14-3-3 蛋白质-蛋白质相互作用的小分子调节
- 批准号:
10607941 - 财政年份:2023
- 资助金额:
$ 7.94万 - 项目类别:
The client specificity of human 14-3-3 protein isoforms
人类 14-3-3 蛋白质亚型的客户特异性
- 批准号:
534610-2019 - 财政年份:2021
- 资助金额:
$ 7.94万 - 项目类别:
Alexander Graham Bell Canada Graduate Scholarships - Doctoral
The client specificity of human 14-3-3 protein isoforms
人类 14-3-3 蛋白质亚型的客户特异性
- 批准号:
534610-2019 - 财政年份:2020
- 资助金额:
$ 7.94万 - 项目类别:
Postgraduate Scholarships - Doctoral
The client specificity of human 14-3-3 protein isoforms
人类 14-3-3 蛋白质亚型的客户特异性
- 批准号:
534610-2019 - 财政年份:2019
- 资助金额:
$ 7.94万 - 项目类别:
Postgraduate Scholarships - Doctoral
Development of 14-3-3 protein/protein interaction agonists as potential therapies for spinal cord injury and stroke
开发 14-3-3 蛋白质/蛋白质相互作用激动剂作为脊髓损伤和中风的潜在疗法
- 批准号:
409940 - 财政年份:2019
- 资助金额:
$ 7.94万 - 项目类别:
Operating Grants
High-throughput profiling of client binding specificity of human 14-3-3 protein isoforms
人类 14-3-3 蛋白亚型的客户结合特异性的高通量分析
- 批准号:
509582-2017 - 财政年份:2017
- 资助金额:
$ 7.94万 - 项目类别:
University Undergraduate Student Research Awards
Modulation of 14-3-3 protein-protein interactions by supramolecular chemistry (B04)
通过超分子化学调节 14-3-3 蛋白质-蛋白质相互作用 (B04)
- 批准号:
247907940 - 财政年份:2014
- 资助金额:
$ 7.94万 - 项目类别:
Collaborative Research Centres
Analysis of neuronal death control target 14-3-3 protein / HMGB1 / Beclin1
神经元死亡控制靶点14-3-3蛋白/HMGB1/Beclin1分析
- 批准号:
26461282 - 财政年份:2014
- 资助金额:
$ 7.94万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Molekulare Stabilisatoren der 14-3-3 Protein-Protein-Wechselwirkung mit Raf und Cdc25 als Ausgangspunkt für innovative Wirkstoffe in der Krebstherapie
14-3-3 蛋白质-蛋白质与 Raf 和 Cdc25 相互作用的分子稳定剂作为癌症治疗中创新活性成分的起点
- 批准号:
81897184 - 财政年份:2008
- 资助金额:
$ 7.94万 - 项目类别:
Research Grants
14-3-3 protein as a regulator of calcium-sensing receptor signalling
14-3-3 蛋白作为钙敏感受体信号传导的调节剂
- 批准号:
nhmrc : 463915 - 财政年份:2007
- 资助金额:
$ 7.94万 - 项目类别:
NHMRC Postgraduate Scholarships